- Joined
- Nov 2, 2006
- Messages
- 1,047
It seems there is a medicine out there targetting the theory the Crohn's is caused by MAP. Myoconda®, the Company's Anti-MAP therapy for the treatment of MAP in Crohn's Disease is a combination of three registered anti-mycobacterial drugs - rifabutin, clarithromycin and clofazimine. These three drugs are widely marketed world-wide for the treatment of mycobacterial and other infections. Myoconda® presents these three compounds in a specific patented combination.
Myoconda® is based on the proposition that MAP infection is a significant factor in Crohn's Disease. Prof. Borody has long been at the forefront of this approach, which is gaining increasing acceptance among gastrointestinal specialists worldwide. Prof. Borody has published significant data demonstrating that patients treated with anti-MAP combination therapy such as that found in Myoconda® experience long-term remission of clinical symptoms and inflammation, some for up to nine years.
http://www.biotech-intelligence.com/html/html/pool_5/d1587ad35f5e210ce29bc55e9e951935.html
Has anyone tried such therapy?
Myoconda® is based on the proposition that MAP infection is a significant factor in Crohn's Disease. Prof. Borody has long been at the forefront of this approach, which is gaining increasing acceptance among gastrointestinal specialists worldwide. Prof. Borody has published significant data demonstrating that patients treated with anti-MAP combination therapy such as that found in Myoconda® experience long-term remission of clinical symptoms and inflammation, some for up to nine years.
http://www.biotech-intelligence.com/html/html/pool_5/d1587ad35f5e210ce29bc55e9e951935.html
Has anyone tried such therapy?